Ionis Pharma (IONS) Spinoff Akcea Therapeutics (AKCA) Files IPO

Akcea Therapeutics, Inc. (NASDAQ: AKCA) today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not been determined. Akcea has applied to list its common stock on the Nasdaq Global Market under the trading symbol "AKCA."

Cowen and Company, Stifel and Wells Fargo Securities are acting as joint book running managers for the offering.

You May Also Be Interested In

• Hitek Global completes $8 million registered direct offering
• TransAlta buys Colorado gas plants for US$1 billion, raises $350 million
• Quantinuum prices IPO at $60 per share for 28 million shares